Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-12-20
1993-07-06
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 68, A61K 31535, C07D27304
Patent
active
052254089
ABSTRACT:
Angiotension II inhibition is exhibited by ##STR1## wherein: R.sup.1 and R.sup.2 are each independently hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, thiophenalkyl, pyridylalkyl, or --R.sup.8 CO.sub.2 R.sup.9 ;
REFERENCES:
patent: 4508718 (1985-04-01), Sircar et al.
patent: 4812462 (1989-03-01), Blankley et al.
patent: 4820843 (1989-04-01), Aldrich et al.
patent: 4870186 (1989-09-01), Aldrich et al.
patent: 4874867 (1989-10-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 5064825 (1991-11-01), Chakravarty et al.
Chiu et al., European Journal of Pharmacology, 157 (1988) pp. 13-21.
E. R. Squibb & Sons Inc.
Gaul Timothy J.
Grumbling Matthew V.
Shah Mukund J.
LandOfFree
Biphenyl oxadiazinone angiotensin II inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenyl oxadiazinone angiotensin II inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl oxadiazinone angiotensin II inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1689695